Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity
Description
Fungal pathogens are considered as serious factors for deadly diseases and are a case of medical concern. Invasive fungal infections also complicate the clinical course of COVID-19, leading to a significant increase in mortality. Furthermore, fungal
